Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Solomon, S.; McMurray, J.; Anand, I.; Ge, J.; Lam, C.; Maggioni, A.; Martinez, F.; Packer, M.; Pfeffer, M.; Pieske, B.; Redfield, M.; Rouleau, J.; V. van Veldhuisen, D.; Zannad, F.; Zile, M.; S. Desai, Akshay; Claggett, Brian; Jhund, P.; Boytsov, S.; Comín-Colet, J.; Cleland, J.; Düngen, H.; Goncalvesova, E.; Katova, T.; K. Kerr Saraiva, J.; Lelonek, M.; Merkely, B.; Senni, M.; J. Shah, Sanjiv; Zhou, Jingmin; Rizkala, A.; Gong, J.; Shi, V.; Lefkowitz, M.

doi:10.1056/NEJMoa1908655

Public

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Shared by NobleBlocks on Sep 1, 2019 • 12:00 AM UTC

Authors:

S. Solomon

J. McMurray

I. Anand

Abstract

BACKGROUND The angiotensin receptor-neprilysin inhibitor sacubitril-valsartan led to a reduced risk of hospitalization for heart failure or death from cardiovascular causes among patients with heart failure and reduced ejection fraction. The effect of angiotensin receptor-neprilysin inhibition in pa...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!